325 related articles for article (PubMed ID: 27397479)
1. Pharmacomodulation of microRNA Expression in Neurocognitive Diseases: Obstacles and Future Opportunities.
Simion V; Nadim WD; Benedetti H; Pichon C; Morisset-Lopez S; Baril P
Curr Neuropharmacol; 2017; 15(2):276-290. PubMed ID: 27397479
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs in Neurocognitive Dysfunctions: New Molecular Targets for Pharmacological Treatments?
Nadim WD; Simion V; Benedetti H; Pichon C; Baril P; Morisset-Lopez S
Curr Neuropharmacol; 2017; 15(2):260-275. PubMed ID: 27396304
[TBL] [Abstract][Full Text] [Related]
3. Targeting respiratory diseases using miRNA inhibitor based nanotherapeutics: Current status and future perspectives.
Mehta M; Satija S; Paudel KR; Malyla V; Kannaujiya VK; Chellappan DK; Bebawy M; Hansbro PM; Wich PR; Dua K
Nanomedicine; 2021 Jan; 31():102303. PubMed ID: 32980549
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA based theranostics for brain cancer: basic principles.
Petrescu GED; Sabo AA; Torsin LI; Calin GA; Dragomir MP
J Exp Clin Cancer Res; 2019 May; 38(1):231. PubMed ID: 31142339
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs in non-small cell lung cancer: Gene regulation, impact on cancer cellular processes, and therapeutic potential.
Petrek H; Yu AM
Pharmacol Res Perspect; 2019 Dec; 7(6):e00528. PubMed ID: 31859460
[TBL] [Abstract][Full Text] [Related]
6. Trials and Tribulations of MicroRNA Therapeutics.
Seyhan AA
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338746
[TBL] [Abstract][Full Text] [Related]
7. A Systematic Review of Current Progresses in the Nucleic Acid-Based Therapies for Neurodegeneration with Implications for Alzheimer's Disease.
Ghaffari M; Sanadgol N; Abdollahi M
Mini Rev Med Chem; 2020; 20(15):1499-1517. PubMed ID: 32400332
[TBL] [Abstract][Full Text] [Related]
8. Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review).
Gambari R; Brognara E; Spandidos DA; Fabbri E
Int J Oncol; 2016 Jul; 49(1):5-32. PubMed ID: 27175518
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA.
Lu TX; Rothenberg ME
J Allergy Clin Immunol; 2018 Apr; 141(4):1202-1207. PubMed ID: 29074454
[TBL] [Abstract][Full Text] [Related]
10. Development of Novel Therapeutic Agents by Inhibition of Oncogenic MicroRNAs.
Nguyen DD; Chang S
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29280958
[TBL] [Abstract][Full Text] [Related]
11. Comparison of different chemically modified inhibitors of miR-199b in vivo.
Duygu B; Juni R; Ottaviani L; Bitsch N; Wit JBM; de Windt LJ; da Costa Martins PA
Biochem Pharmacol; 2019 Jan; 159():106-115. PubMed ID: 30452907
[TBL] [Abstract][Full Text] [Related]
12. miR-10b-5p expression in Huntington's disease brain relates to age of onset and the extent of striatal involvement.
Hoss AG; Labadorf A; Latourelle JC; Kartha VK; Hadzi TC; Gusella JF; MacDonald ME; Chen JF; Akbarian S; Weng Z; Vonsattel JP; Myers RH
BMC Med Genomics; 2015 Mar; 8():10. PubMed ID: 25889241
[TBL] [Abstract][Full Text] [Related]
13. Current Status of microRNA-Based Therapeutic Approaches in Neurodegenerative Disorders.
Paul S; Bravo Vázquez LA; Pérez Uribe S; Roxana Reyes-Pérez P; Sharma A
Cells; 2020 Jul; 9(7):. PubMed ID: 32679881
[TBL] [Abstract][Full Text] [Related]
14. Targeted Suppression of miRNA-33 Using pHLIP Improves Atherosclerosis Regression.
Zhang X; Rotllan N; Canfrán-Duque A; Sun J; Toczek J; Moshnikova A; Malik S; Price NL; Araldi E; Zhong W; Sadeghi MM; Andreev OA; Bahal R; Reshetnyak YK; Suárez Y; Fernández-Hernando C
Circ Res; 2022 Jun; 131(1):77-90. PubMed ID: 35534923
[TBL] [Abstract][Full Text] [Related]
15. miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart.
Bernardo BC; Ooi JY; Lin RC; McMullen JR
Future Med Chem; 2015; 7(13):1771-92. PubMed ID: 26399457
[TBL] [Abstract][Full Text] [Related]
16. p73-Governed miRNA Networks: Translating Bioinformatics Approaches to Therapeutic Solutions for Cancer Metastasis.
Logotheti S; Marquardt S; Pützer BM
Methods Mol Biol; 2019; 1912():33-52. PubMed ID: 30635889
[TBL] [Abstract][Full Text] [Related]
17. Post-transcriptional gene-expression regulation by micro RNA (miRNA) network in renal disease.
Kaucsár T; Rácz Z; Hamar P
Adv Drug Deliv Rev; 2010 Nov; 62(14):1390-401. PubMed ID: 20940025
[TBL] [Abstract][Full Text] [Related]
18. The Emerging Role of MitomiRs in the Pathophysiology of Human Disease.
Duarte FV; Palmeira CM; Rolo AP
Adv Exp Med Biol; 2015; 888():123-54. PubMed ID: 26663182
[TBL] [Abstract][Full Text] [Related]
19. Delivery of therapeutic miRNA using polymer-based formulation.
Ban E; Kwon TH; Kim A
Drug Deliv Transl Res; 2019 Dec; 9(6):1043-1056. PubMed ID: 31049843
[TBL] [Abstract][Full Text] [Related]
20. Progress in microRNA delivery.
Zhang Y; Wang Z; Gemeinhart RA
J Control Release; 2013 Dec; 172(3):962-74. PubMed ID: 24075926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
